ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0140

Estimation of 10-year Cardiovascular (CV) Risk and Traditional CV Risk Factors Distribution in Patients with Rheumatoid Arthritis from Three Italian Macro-areas

Fabiola Atzeni1, Fabio Cacciapaglia2, Elena Bartoloni Bocci3, Matteo Piga4, Garifallia Sakellariou5, Ombretta Viapiana6, Alessandro Giollo7, SIMONE PARISI8, Maria Sole Chimenti9, Ennio Giulio Favalli10, Addolorata Corrado11, Eleonora Celletti12, Ivan Giovannini13, Serena Guiducci14, Elisa Gremese15, Andreina Manfredi16, Francesca Romana Spinelli17 and Gian Luca Erre18, and "Cardiovascular Obesity and Rheumatic DISeaases" Study Group of the Italian Society of Rheumatology, 1University of Messina, Italy, Messina, Italy, 2Rheumatology Unit DiMePRe-J, University and AOU Policlinico of Bari, Italy, Bari, Italy, 3Rheumatology Unit. Department of Medicine, Perugia, Perugia, Italy, 4Rheumatology Unit - Department of Medical Sciences and Public Health, University of Cagliari, Monserrato, Italy, 5Department of Internal Medicine and Medical Therapy, University of Pavia, and Istituti Clinici Scientifici Maugeri IRCCS Pavia,, Pavia, Italy, 6Rheumatology Unit, University of Verona, Verona, Italy, 7Azienda Ospedale Università Padova, Padova, Padua, Italy, 8Rheumatology Unit, Azienda Ospedaliero Universitaria Città della Salute e della Scienza di Torino, TURIN, Italy, 9Rheumatology, Allergology and Clinical Immunology, University of Rome Tor Vergata, Roma, Italy, 10ASST Gaetano Pini-CTO, Milan, Lombardia, Italy, 11Rheumatology Unit, University of Foggia, Foggia, Italy, 12Medical Clinic, SS. Annunziata Hospital of Chieti, Department of Medicine and Science of Aging, G. D'Annunzio University of Chieti-Pescara, Chieti, Italy, 13Azienda Sanitaria Universitaria Friuli Centrale, Udine, Udine, Italy, 14University of Florence, Pistoia, Italy, 15Catholic University of the Sacred Heart, Rome, Rome, Italy, 16University of Modena and Reggio Emilia, Modena, 17Sapienza University of Rome, Rome - Italy, Roma, Rome, Italy, 18Rheumatology Unit - University of Sassari, Sassari, Italy

Meeting: ACR Convergence 2024

Keywords: Access to care, Cardiovascular, Quality Indicators, rheumatoid arthritis, socioeconomic factors

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 16, 2024

Title: Epidemiology & Public Health Poster I

Session Type: Poster Session A

Session Time: 10:30AM-12:30PM

Background/Purpose: Geographic origins can significantly impact people’s health, particularly in Italy, where regional health disparities are among the most pronounced [1]. Rheumatoid arthritis (RA) is characterized by increased cardiovascular (CV) disease comorbidity. Traditional CV risk factors in RA patients are more closely related to surrogate CV disease markers than inflammatory indices [2]. This study aimed to compare the prevalence of CV risk factors and the cardiovascular risk score values among groups of RA patients from different macro-areas in Italy.

Methods: This study is a cross-sectional analysis of a longitudinal cohort of 1,421 adult RA patients (357 from the North, 228 from the Center, and 836 from the South of Italy). Several types of information were collected, including demographics, clinical assessments, smoking habits, Body Mass Index (BMI), total cholesterol levels, arterial hypertension, dyslipidemia, use of antihypertensive drugs and statins, obesity (BMI ≥30), and diabetes. The ‘Progetto Cuore’ (PGC), ERS-RA, and Framingham risk scores were also evaluated.

Results: RA patients in the North of Italy are older and have a prolonged disease duration but have lower disease activity (DAS28) and higher remission rates (Table I). Overall, the most prevalent CV risks were dyslipidemia (65.7%) and hypertension (49.7%). When comparing RA patients among the three macro-areas, hypertension was significantly more prevalent in the South (53.8%, p=0.001), and dyslipidemia was less prevalent in the Center (56.5%, p=0.006). At the same time, statin use was less common in the North (14.1%, p=0.010). Although obesity prevalence did not differ among the three macro-areas, BMI values were significantly lower in the North. Regarding health habits, smokers were significantly more prevalent in the Central regions (39.2%, p< 0.001). The ERS-RA and Framingham risk scores, but not the PGC algorithm, significantly differed across Italian regions (Table II).

Conclusion: This study suggests that geographical differences in Italy may influence the CV risk profile in RA patients. Different genetic backgrounds, lifestyles, and dietary habits may explain the observed differences. Further research is needed to assess how geographic and sociocultural factors contribute to CV risk and to develop targeted strategies to improve CV outcomes.

References.
1. Franzini L, Giannoni M. BMC Public Health. 2010;10:296.
2. Sandoo A, et al.  Arthritis Res Ther 2013;15:R203.

Supporting image 1

Table I

Supporting image 2

Table II


Disclosures: F. Atzeni: None; F. Cacciapaglia: AbbVie/Abbott, 2, 6, Boehringer-Ingelheim, 2, 6, Eli Lilly, 6, Galapagos, 6, Janssen, 2, 6, Pfizer, 6; E. Bartoloni Bocci: None; M. Piga: None; G. Sakellariou: None; O. Viapiana: None; A. Giollo: AbbVie/Abbott, 6, Boehringer-Ingelheim, 6, Eli Lilly, 6, UCB, 6; S. PARISI: None; M. Chimenti: None; E. Favalli: AbbVie, 12, Consultancy/speaker fees from, Bristol-Myers Squibb(BMS), 12, Consultancy/speaker fees from, Celltrion, 12, Consultancy/speaker fees from, Eli Lilly, 12, Consultancy/speaker fees from, Galapagos, 12, Consultancy/speaker fees from, Janssen, 12, Consultancy/speaker fees from, MSD, 12, Consultancy/speaker fees from, Novartis, 12, Consultancy/speaker fees from, Pfizer, 12, Consultancy/speaker fees from, UCB Pharma, 12, Consultancy/speaker fees from; A. Corrado: None; E. Celletti: None; I. Giovannini: None; S. Guiducci: None; E. Gremese: None; A. Manfredi: None; F. Spinelli: Abbvie, 2, 6, Eli Lilly, 6, Galapagos, 2, GlaxoSmithKlein(GSK), 6, Pfizer, 6; G. Erre: None.

To cite this abstract in AMA style:

Atzeni F, Cacciapaglia F, Bartoloni Bocci E, Piga M, Sakellariou G, Viapiana O, Giollo A, PARISI S, Chimenti M, Favalli E, Corrado A, Celletti E, Giovannini I, Guiducci S, Gremese E, Manfredi A, Spinelli F, Erre G. Estimation of 10-year Cardiovascular (CV) Risk and Traditional CV Risk Factors Distribution in Patients with Rheumatoid Arthritis from Three Italian Macro-areas [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/estimation-of-10-year-cardiovascular-cv-risk-and-traditional-cv-risk-factors-distribution-in-patients-with-rheumatoid-arthritis-from-three-italian-macro-areas/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/estimation-of-10-year-cardiovascular-cv-risk-and-traditional-cv-risk-factors-distribution-in-patients-with-rheumatoid-arthritis-from-three-italian-macro-areas/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology